Not applicableStudy completedNCT00499395
What this trial is testing
Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer
Who this might be right for
Colorectal CancerMetastatic Cancer
UNC Lineberger Comprehensive Cancer Center 4